Neurology News

WASHINGTON — Compared with other hypnotics, a class of insomnia hypnotics did not raise the risk for death or inpatient COPD exacerbations, according to research presented at the American Thoracic Society International Conference.

There were increases in rare pediatric intracranial infections over the past 3 years that coincided with notable spikes in respiratory viruses, although the infections remained rare, according to two reports published Thursday in MMWR.

BOSTON — More than half of patients with early MS had no disease progression over 9 years when taking Ocrevus, according to Ashish Pradhan, MD, in this Healio video.

Disease activity in relapsing MS patients significantly fell following treatment with frexalimab, a novel second-generation investigational anti-CD40L antibody developed by Sanofi, according to a company press release.

Medicare patients who were treated by osteopathic and allopathic hospitalists received similar quality and costs of care, according to the results of research published in Annals of Internal Medicine.

With the rapid rise of interest rates in the last year, many physicians might be interested and surprised to learn where extremely low rates still exist.

Most medical practices subject to data security regulations of the HIPAA Security Rule have adopted administrative, physical and technical safeguards for electronic protected health information in accordance with the HIPAA Security Rule.

Over the past few years, products based on CBD and medical marijuana have become widely available and accepted as treatments for various ailments.

African American men and women remain at higher risk for stroke even as overall stroke rates are decreasing, Bruce Ovbiagele, MD, MSc, MAS, MBA, MLS, says in this Healio video.

The combination of intratumoral DNX-2401 and pembrolizumab appeared safe and provided “notable survival benefits” for select patients with recurrent glioblastoma, according to a study published in Nature Medicine.